| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 29 |
| 1 | EMPAGLIFLOZIN | 27 |
| 2 | METHOTREXATE SODIUM | 23 |
| 3 | MYCOPHENOLATE MOFETIL | 20 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 20 |
| 5 | METHOTREXATE | 19 |
| 6 | TACROLIMUS | 19 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| 8 | TACROLIMUS OINTMENT 0.1% | 18 |
| 9 | ABATACEPT | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENADIONE | 1 | 0.0072 |
| 1 | TALQUETAMAB-TGVS | 2 | 0.0013 |
| 2 | TECLISTAMAB-CQYV | 3 | 0.0013 |
| 3 | GOLIMUMAB | 13 | 0.0010 |
| 4 | MOSUNETUZUMAB | 1 | 0.0009 |
| 5 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 6 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 7 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 8 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 9 | ALBENDAZOLE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 33 | 0.0003 |
| 5 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Antimycobacterial [EPC] | 6 | 0.0002 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |